Choisissez votre pays / Select your country

Ninalia NIPT The prenatal trisomy screening test based on maternal blood sample

Monitoring your patients

Patient’s journey according to the decision tree:

Non-invasive sample
  • Ultrasound
  • Maternal Serum Markers  (MSM)
  • Non-Invasive Prenatal Testing (NIPT)
Invasive sample
  • Amniocentesis
  • Chorionic villus sampling

Trisomy 21 diagnostic strategy with NIPT

N.B: For signs on ultrasound or risk greater than 1/10 according to maternal serum markers, confirmation of the diagnosis by fœtal karyotype testing on invasive sample is required.

Please contact Eurofins Biomnis geneticists at should you need further information.

The advantages of Ninalia NIPT in the diagnosis of trisomies 13, 18 and 21

  • An excellent detection rate : 99%*
  • Reduced exposure to the risk of foetal loss by avoiding useless invasive procedure
  • Can be used for twin pregnancies (combined screening in the 1st trimester is not currently recommended for twin pregnancies).
  • Can be performed within the context of pregnancies with donated eggs and pregnancies in transplant patients, unlike other tests available on the market.
  • Eurofins Biomnis genetists at your service to advise you on diagnostic approach

Find your nearest testing centre As Ninalia NIPT requires a specific sample tube, don’t forget to make an appointment in advance with your local laboratory for specimen collection.

Vous avez refusé de partager votre position.
Désolé. Nous n'arrivons pas à savoir où vous êtes...
Il faut nous autoriser à voir votre position...
Votre navigateur ne possède pas cette fonctionnalité.

Partner laboratories

out of laboratories in total out of laboratories in total